bhanushahmd.

Clinical clarity for your body and hormones.

News

Surgical Menopause Timing: A Critical Factor for Long-Term Heart Health

A new systematic review and meta-analysis in JAMA Network Open puts the spotlight on exactly that question, evaluating how the timing of surgical or iatrogenic menopause relates to long-term…

Surgical Menopause Timing: A Critical Factor for Long-Term Heart Health

Why the Timing of Surgical Menopause Now Belongs on Your Risk Radar

If you are facing, or have already had, surgical removal of both ovaries before natural menopause, the age at which that happened is not a surgical footnote. It is a cardiovascular variable. A new systematic review and meta-analysis in JAMA Network Open puts the spotlight on exactly that question, evaluating how the timing of surgical or iatrogenic menopause relates to long-term cardiovascular disease morbidity and mortality in women.

The study pulls together existing evidence to test one core association: does earlier iatrogenic menopause translate into measurably higher heart and vascular risk years down the line? The framing matters because most clinical conversations about oophorectomy focus on cancer prevention, genetic risk, or pelvic pain, not on the cardiovascular ledger that comes after.

What This Changes at Your Next Appointment

Bring the date. If you know the exact age at which your ovaries were removed, or when you entered iatrogenic menopause through other medical treatment, that number is now a legitimate input into your cardiovascular risk assessment. Ask your clinician to:

  • Document your age at iatrogenic menopause in your record as a discrete data point, not buried in an operative note.
  • Cross-check it against your current cardiovascular risk calculation.
  • Review whether your lipid panel, blood pressure, and inflammatory markers are being tracked on a schedule appropriate for someone with a shortened estrogen exposure window.

What to Watch Going Forward

The meta-analysis confirms a signal that has been building in the literature: the timing of iatrogenic menopause is not a variable you can reverse, but it is one you can recognize early, document accurately, and compensate for in screening. There is no undoing the surgery, but there is aggressive, evidence-based heart protection.

Until formal guidelines catch up to this evidence, your best move is to treat your age at iatrogenic menopause the way your clinician already treats a family history of early heart disease: as a reason to screen sooner, screen more thoroughly, and intervene earlier.

Your Office Script

Walk in with one sentence ready: "My ovaries were removed at age ___, and I would like that factored into my cardiovascular risk assessment going forward." If your provider pauses or has not heard this framing before, that gap is precisely what the new meta-analysis is asking the field to close. Request a baseline workup if you have not had one since the surgery, and ask for a written summary of your updated risk profile before you leave the room.